For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of this treatment and Attruby represents a true advancement . These novel therapies stabilize the transthyretin protein, preventing its destructive build-up and reducing the severity of th